Completed

January 2013 - December 2014

Retinal vessel function to identify and assess diabetic retinopathy in coronary artery disease patients

Research Details

  • Type of funding: Fight for Sight Small Grant Award
  • Grant Holder: Dr Rebekka Heitmar
  • Region: West Midlands
  • Institute: Aston University
  • Priority: Causes
  • Eye Category: Retinal vascular

Diabetes is the leading cause of eye disease in the UK, and increased plasma von Willebrand factor (vWf) marks endothelial damage and demonstrates a vascular cause.

However, the progression of the disease is variable and the ability to accurately detect those at greatest risk of serious ocular and cardiovascular disease is a much sought after clinical need, which can enable the most effective channelling of preventative resources.

Unfortunately, none of the standard methods of assessing eye vessels evaluates the function of the vessels in ‘real time’.

Researchers have recently developed and validated a new non-invasive method for assessing retinal vessel function that provides better information than a static view as offered by photography.

A normal retinal vessel responds to flickering light by dilating, and upon flicker cessation, returns to baseline over a short period of time. An abnormal response is a longer time needed to reach maximum vessel dilation and/ or a change in maximum dilation when a multiple stimulation protocol is applied, implying cause.

The aim of this study is to determine if the new and validated method of assessing vascular function of the retinal vessels is of sufficient sensitivity to differentiate those diabetics with and without coronary artery disease (CAD). This will provide a new non-invasive tool in the clinical management of diabetes.